JUSTIN AMADOR: Open Payments
NPI 1760772321 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$774 in 27 payments from 7 companies in 2025. Trend: 2023 $198 · 2024 $859 · 2025 $774
Food & beverage: $774
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 10 | $337 |
| Gilead Sciences, Inc. | 10 | $276 |
| EMD Serono, Inc. | 3 | $50 |
| ABBVIE INC. | 1 | $34 |
| Theratechnologies Inc. | 1 | $31 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $20 |
Products named: APRETUDE, CABENUVA, MAVYRET, Biktarvy, EGRIFTA, SHINGRIX, M-M-R II.
Industry payments across CA — which companies pay providers there.
